Prevnar 13 4.4 mcg

PREVNAR 13 4.4 MCG is a pneumococcal vaccine designed to protect against pneumococcal disease. This suspension is administered intramuscularly and is manufactured by Pfizer Canada ULC.

PREVNAR 13 4.4 MCG is used to help prevent pneumococcal disease, which can cause serious infections like pneumonia, meningitis, and bloodstream infections. It is typically recommended for infants, children, and adults who are at increased risk of pneumococcal infection. The vaccine works by stimulating the body's immune system to produce antibodies against the pneumococcal bacteria.

Common effects of PREVNAR 13 4.4 MCG may include redness, swelling, or pain at the injection site. Some individuals might experience mild fever, fatigue, or muscle aches. These effects are usually temporary and resolve on their own. Severe side effects are rare but should be reported to a healthcare provider.

PREVNAR 13 4.4 MCG should be used with caution in individuals with a history of severe allergic reactions to any component of the vaccine. It is important to inform your healthcare provider about any allergies or medical conditions before receiving the vaccine. The vaccine should be stored properly to maintain its effectiveness.

PREVNAR 13 4.4 MCG may interact with certain medications or other vaccines. It is advisable to discuss all current medications with a healthcare provider before receiving the vaccine. Additionally, the vaccine should not be mixed with other vaccines in the same syringe unless specifically instructed by a healthcare provider.